Fibromyalgia syndrome: The pharmacological treatment options;Il trattamento farmacologico della sindrome fibromialgica

Reumatismo

Volumn 60, Issue SUPPL. 1, 2007, Pages 50-58

  Sarzi Puttini, Piercarlo ^a   Torta, R ^b   Marinangeli, F ^c   Biasi, G ^d   Spath, M ^e   Buskila, D ^f   Gracely, R H ^g   Giamberardino, M A ^h   Bazzichi, L ⁱ   Cazzola, M ^j   Di Franco, M ^k   Stisi, S ^l   Salaffi, F ^m   Casale, R ⁿ   Leardini, G ^o   Gorla, R ^p   Marsico, A ^q   Carignola, R ^b   Altomonte, L ^r   Ceccherelli, F ^s   Cassisi, G ^t   Arioli, G ^u   Alciati, A ^a   Atzeni, F ^a   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h UNIVERSITY OF CHIETI   (Italy)

ⁱ UNIVERSITY OF PISA   (Italy)

^j Unit of Rehabilitative Medicine 'Hospital of Circolo'   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l G RUMMO HOSPITAL   (Italy)

^m UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

ⁿ IRCCS   (Italy)

^o SS Giovanni e Paolo Hospital   (Italy)

^p UNIVERSITY OF BRESCIA   (Italy)

^q Hospital of Taranto   (Italy)

^r S EUGENIO HOSPITAL   (Italy)

^s UNIVERSITY OF PADOVA   (Italy)

^t Rheumatology Branch   (Italy)

^u General Hospital of Pieve di Coriano   (Italy)

more..

Author keywords

Antiepileptics; Non pharmacologic approach; Nonsteroidal anti inflammatory drugs; Opioids; Pharmacologic approach

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT;

FIBROMYALGIA; HUMAN; REVIEW;

ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; FIBROMYALGIA; HUMANS;

EID: 69249221648     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2008.1s.50     Document Type: Article

References (73)

1. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J. Rheumatol 2005; 75: 6-21.
2. Shmerling RH. A review of fibromyalgia. Am. J Manag Care 2004; 10: 794-800.
3. Wolfe F, Smythe HA, Yunus MD. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
4. Sim J, Adams N. Physical and other non-pharmacological interventions for fibromyalgia. Bailliere's Clin Rheumatol 1999; 13: 507-23.
5. Offenbaecher M, Stucki G. Physical therapy in the treatment of fibromyalgia. Scand J Rheumatol 2000; 29: 78-85.
6. Busch A, Schachter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2002 (3): CD003786.
7. Keel PJ. Pain management strategies and team approach. Bailliere's Clin Rheumatol 1999; 13: 493-506.
8. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F. Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 2008; 37: 353-65.
9. Cazzola M, Sarzi-Puttini P, Buskila D, Atzeni F. Pharmacological treatment of fibromyalgia. Reumatismo. 2007; 59: 280-91.
10. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum. 2000; 43: 378-85.
11. Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol 2006; 25 (Suppl 1): S22-9.
12. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR. EULAR evidencebased recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008; 67: 536-41.
13. Clauw DJ. Pharmacotherapy for patients with fibromyalgia. J Clin Psychiatry. 2008; 69 Suppl 2: 25-9.
14. No authors listed. Now we know: why opioids don't work against fibromyalgia pain. Recent study reveals reduced opioid receptor availability in the brain; but a new FDA-approved drug brings relief. Health News 2008; 14: 3.
15. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006; 23, 174: 1589-94.
16. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998; 18: 13-9.
17. Bennett RM, Kamin M, Karin R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain. Am J Med 2003; 114: 537-45.
18. Bennett RM, Schein J, Kosinski MR, Hewitt DJ, Jordan DM, Rosenthal NR: Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005; 53: 519-27.
19. Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain. 2008. [Epub ahead of print].
20. Harris JD. Management of expected and unexpected opioid-related side effects. Clin J Pain. 2008; 24: S8-S13.
21. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R Increased Neural Sympathetic Activationin Fibromyalgia Syndrome Ann NY Acad Sci 2006; 1069: 109-117.
22. Gupta A, Silman AJ. Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther 2004; 6: 98-106.
23. McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Dickens C, Gupta A, Macfarlane GJ. Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 2005; 7: 992-1000.
24. Torta R. Depression as Systemic Disease: the Antidepressants Spectrum of Action. Psycho-Oncology 2006; 15: 3-4.
25. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999; 40: 57-63.
26. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003; 65: 528-33.
27. Carta MG, Cardia C, Mannu F, Istilla G, Hardoy MC, Anedda C, et al. The high frequency of manic symptoms in fibromyalgia does influence the choice of treatment? Clin Pract Epidem Ment Health 2006; 2: 36.
28. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292: 2388-95.
29. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39: 1852-9.
30. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000; 32: 305-16.
31. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 2005; 71: 483-90.
32. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000; 41: 104-13.
33. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 2000; 15: 659-66.
34. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994; 23: 255-9.
35. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995; 61: 445-9.
36. Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Eur J Pain 2000; 4: 27-35.
37. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, doubleblind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112: 191-7.
38. Torta R, Lacerenza M. Depressione e Dolore, Utet, Milano 2002; 199.
39. Torta R, Berra C. La terapia neuropsicofarmacologica nel dolore. In: Torta R., Mussa A: PsicOncologia. Il modello biopsicosociale. Centro Scientifico Editore, Torino, 2007.
40. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, doubleblind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002; 112: 191-7.
41. Perrot S, Maheu E, Javier RM, Eschalier A, Coutaux A, LeBars M, et al. Guidelines for the use of antidepressants in painful rheumatic conditions. Eur J Pain. 2006; 10: 185-92.
42. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005; 96: 399-409.
43. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50: 2974-84.
44. Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136: 432-44.
45. Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol Clin Exp 2004; 19: 27-35.
46. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119: 5-15.
47. Arnold LM. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006; 8: 212-32.
48. Santandrea S, Montrone F, Sarzi-Puttini P, Boccassini L, Caruso I. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 1993; 21: 74-80.
49. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum 2004; 51: 9-13.
50. Torta R, Bovero A. L'intervento integrato fra psicoterapia breve ed antidepressivi nel dolore oncologico. Il Giornale di Psiconcologia, 2008, in press.
51. Benedetti F. What do you expect from this treatment? Changing our mind about clinical trials. Pain 2007; 128: 193-4.
52. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 2007; 20: 435-9.
53. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-34.
54. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995; 311: 1047-52.
55. Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998; 87: 1360-6.
56. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, et al. A summary of mechanistic hypotheses of gabapentin pharmacology [review]. Epilepsy Res 1998; 29: 233-49.
57. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007; 56: 1336-44.
58. 2 subunit of a calcium channel. J Biol Chem 1996; 271: 5768-76.
59. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, et al. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42: 229-36.
60. Maneuf YP, Hughes J, McKnight AT. Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudal trigeminal nucleus slices. Pain 2001; 93: 191-6.
61. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73.
62. Arnold LM, Crofford LJ, Martin SA, Young JP, Sharma U. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. Pain Med 2007; 8: 633-8.
63. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, Sharma U. A Randomized, Doubleblind, Placebo-Controlled, Phase III Trial of Pregabalin in the Treatment of Patients with Fibromyalgia. J Rheumatol 2008 Feb 15 [Epub ahead of print].
64. Färber L, Stratz TH, Brückle W, Späth M, Pongratz D, Lautenschläger J, et al. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebocontrolled multicenter trial in 418 patients. Int J Clin Pharmacol Res 2001; 21: 1-13.
65. Späth M, Stratz T, Färber L, Haus U, Pongratz D. Treatment of fibromyalgia with tropisetron-dose and efficacy correlations. Scand J Rheumatol (Suppl.) 2004; (119): 63-6.
66. Papadopoulos IA, Georgiou PE, Katsimbri PP, Drosos AA. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study. Clin Rheumatol 2000; 19: 6-8.
67. Koeppe C, Schneider C, Thieme K, Mense S, Stratz T, Müller W, Flor H. The influence of the 5-HT3 receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study. Scand J Rheumatol Suppl 2004; (119): 24-7.
68. Wood PB, Kablinger AS, Caldito GS. Open trial of pindolol in the treatment of fibromyalgia. Ann Pharmacother 2005; 39: 1812-6.
69. Jones KD, Deodhar P, Lorentzen A, Bennett RM, Deodhar AA. Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum. 2007; 36: 357-79.
70. Sörensen J, Bengtsson A, Bäckman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995; 24: 360-5.
71. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 2006 12: 23-7.
72. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics 2007; 8: 67-74.
73. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 2006; 8: 218.